Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Bouvenot

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|July 24, 2003
[Is it still ethical to conduct clinical trials against a placebo? A review of the ethical and methodological controversy]Gilles Bouvenot
Bulletin De L'Academie Nationale De Medecine|June 2, 2006
[Drug evaluation by the French National Health Authority for reimbursement decisions]Gilles Bouvenot
La Revue Du Praticien|April 3, 2020
[Dangerousness of NSAID banal prescription:awareness is essential]Gilles Bouvenot
La Revue Du Praticien|April 3, 2020
[Pricing of medicines in France]Gilles Bouvenot
La Revue Du Praticien|June 2, 2026
[Marketing authorisation of new drugs: a worrying observation]Gilles Bouvenot
La Revue Du Praticien|December 13, 2022
[Drug costs: a threat to our health care system ?]Gilles Bouvenot
La Revue Du Praticien|January 23, 2026
[The French and their medications: between dependence and mistrust?]Gilles Bouvenot
Therapie|June 24, 2006
[The French National Medicines Assessment Committee, innovation and therapeutic progress]Gilles Bouvenot
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Quantification of pharmacological progress by the French National Health Authorities]Gilles Bouvenot
La Revue Du Praticien|November 18, 2021
[Two decades later, the polypill revisited]Gilles Bouvenot
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|July 24, 2003
[Is it still ethical to conduct clinical trials against a placebo? A review of the ethical and methodological controversy]Gilles Bouvenot
Bulletin De L'Academie Nationale De Medecine|June 2, 2006
[Drug evaluation by the French National Health Authority for reimbursement decisions]Gilles Bouvenot
La Revue Du Praticien|April 3, 2020
[Dangerousness of NSAID banal prescription:awareness is essential]Gilles Bouvenot
La Revue Du Praticien|April 3, 2020
[Pricing of medicines in France]Gilles Bouvenot
La Revue Du Praticien|June 2, 2026
[Marketing authorisation of new drugs: a worrying observation]Gilles Bouvenot
La Revue Du Praticien|December 13, 2022
[Drug costs: a threat to our health care system ?]Gilles Bouvenot
La Revue Du Praticien|January 23, 2026
[The French and their medications: between dependence and mistrust?]Gilles Bouvenot
Therapie|June 24, 2006
[The French National Medicines Assessment Committee, innovation and therapeutic progress]Gilles Bouvenot
Bulletin De L'Academie Nationale De Medecine|January 2, 2007
[Quantification of pharmacological progress by the French National Health Authorities]Gilles Bouvenot
La Revue Du Praticien|November 18, 2021
[Two decades later, the polypill revisited]Gilles Bouvenot
Pageof 5